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a  b  s  t  r  a  c  t
INTRODUCTION:  Upper  Gastrointestinal  Tract  (UGIT)  malignancy  is  an  increasing  problem  in  western
society  and  its  prognosis  is generally  poor.  The  prognosis  dims  even  further  with  the presence  of  loco
regional  recurrences  or distant  metastasis.  This  article  looks  at the  feasibility  and  potential  beneﬁt  from
resection  of  non-hepatic,  non-nodal  metastases  and  recurrences.
PRESENTATION OF  CASE:  Case  1. A  72-year-old  male  who  underwent  total gastrectomy  for  a gastric  ade-
nocarcinoma  presented  with  a splenic  mass  40 months  later  and  underwent  a splenectomy.  He  is disease
free  at  30  months  post-metastectomy.  Case  2. A 54-year-old  male  with  oesophagogastric  junctional
adenocarcinoma,  underwent  an  Ivor-Lewis  oesophagectomy.  He  developed  a  distal  pancreatic  mass  at
24  months  follow-up  and  underwent  distal  pancreatectomy  and  splenectomy.  He  is disease  free  at  12
months  post-metastectomy.  Case  3.  A 75-year-old  male  underwent  subtotal  gastrectomy  for  lesser  cur-
vature  adenocarcinoma.  At 42  months  follow-up,  he  developed  solitary  abdominal  wall  recurrence.  This
was  locally  resected  with  clear  margins.  After  12  months,  he  developed  another  full thickness  abdominal
wall  recurrence  with  involvement  of  the  hepatic  ﬂexure.  Enbloc  resection  including  right hemicolectomy
was  performed  and  he  is  disease  free  at 3 months.
DISCUSSION: There  is very  scarce  literature  on  resection  of  non-hepatic,  non-nodal  recurrences/distant
metastasis  in  oesophagogastric  cancers.  Based  on  these  cases,  a surgical  resection  in selected  cases  may
provide  prolonged  survival  with  good  quality  of  life.
CONCLUSION: Resection  for isolated  recurrences  and  metachronous  metastasis  from  UGIT  cancers  may
be  worthwhile,  especially  if patients  have  minimal  co-morbidities.
©  2014  The  Authors.  Published  by Elsevier  Ltd.  on behalf  of  Surgical  Associates  Ltd.  This  is  an  open
he  CCaccess article  under  t
. Introduction
UGIT malignancy is an increasing problem in western society.
enerally, the prognosis for oesophageal and gastric cancers is
oor at best.1,2 Gastric cancer is the 4th most common cancer
orldwide3 and 11th in Australia.4 It is more common in men  and
as an incidence of 11.9 per 100,000 in men, 5.5 per 100,000 in
omen with a combined incidence of 8.7 per 100,000.4 Combined
 year survival ﬁgures sit at 17.5%.5
Oesophageal cancer is the 8th most common in the world,3 and
5th in Australia,4 with an incidence of 5.8 combined and 8.4 and
.1 per 100,000 population respectively for males and females.4 The
-year survival for oesophageal cancer is a meagre 12.5% across all
he stages.5
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The poor prognosis that afﬂicts western patients is not mirrored
in the East Asian population. The incidence of gastric cancer in East
Asia is as high as 30 per 100,0006 but 5-year survival rates are
up to 60% in some Japanese studies.6 Screening programmes and
early diagnosis may  be partly responsible for this difference. Liter-
ature from Japan suggests more radical surgery may  be beneﬁcial
as well.6
While the results of the MAGIC trial,7 with perioperative
chemotherapy, indicate an improvement in survival in the Stage
2 and 3 groups, the prognosis for M1  (AJCC) or Stage 4 disease
still remains poor (4% ﬁve year survival) according to the AJCC.8
Metachronous recurrences and metastasis are seldom treated with
curative intent and palliative chemotherapy or radiotherapy, if any-
thing, is usually the preferred treatment modality.
Data on surgical resection of isolated metastases from UGIT
malignancy is sparse with variable outcomes.9–12On this background we present three cases with good survival
and quality of life after surgical resection of metachronous
isolated non hepatic metastases form oesophago-gastric
carcinomas.
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months with a lump in the abdominal wall in the right upper quad-Fig. 1. Primary gastric adenocarcinoma.
. Case presentation
.1.  Case 1
A  72-year-old male, on follow up after a total gastrectomy for a
T3 N0 proximal gastric cancer, was found to have a splenic mass
n annual surveillance CT scan 40 months after the initial surgery.
here was no evidence of any other metastases. Endoscopy was
ormal. The case was discussed at the unit multidisciplinary meet-
ng (MDM)  and a decision to perform an exploration with view
o resection was taken in view of isolated nature of the possible
etastasis. He underwent a laparotomy and splenectomy, which
onﬁrmed gastric carcinoma identical to that previously seen on the
astrectomy specimen. He was offered chemotherapy and declined.
e has been followed in outpatients and at 30 months remains
isease-free (Figs. 1 and 2).
.2. Case 2
A  54-year-old male had previously undergone an Ivor-Lewis
esophagectomy after neoadjuvant chemo radiotherapy for a mod-
rately differentiated pT3 N2 junctional adenocarcinoma starting
t 36 cm from the incisors. This was on a background of DM and
ypertension.
Fig. 2. Splenic metastasis.Fig. 3. Primary oesophageal adenocarcinoma.
At 24 months follow-up, he was  found to have a 5 cm lesion in
the tail of the pancreas on a CT scan. Further imaging was inconclu-
sive as to the nature of the lesion. The case was discussed at the unit
MDM and he subsequently underwent a distal pancreatectomy and
splenectomy. Histology revealed this to be a mucinous adenocar-
cinoma in keeping with the previous oesophageal primary. There
was extensive neural invasion. He recovered well initially but was
readmitted with a small bowel obstruction a month after surgery
and underwent further laparotomy. A single band adhesion was
found and divided and he had an uneventful recovery after this. He
underwent adjuvant chemotherapy and remains disease free at 12
months post-metastectomy (Figs. 3 and 4).
2.3. Case 3
A  75 year-old male had previously undergone a subtotal gastrec-
tomy for a PT4 N2 gastric carcinoma. This was on a background of
hypertension and mild asthma. He was given a course of adjuvant
chemoradiotherapytherapy.
He underwent follow-up as per unit protocol with regular clin-
ical examinations and imaging, He presented to follow-up at 42rant. Ultrasound revealed an intramuscular lesion invading anterior
and posterior rectus sheaths, and a ﬁne needle aspirate conﬁrmed
this to be adenocarcinoma .The lump, 25 mm × 20 mm × 25 mm
Fig. 4. Pancreatic metastasis.
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sFig. 5. Primary gastric adenocarcinoma.
as excised in its entirety, along with a cuff of muscle. Margins were
eported to be clear, with no evidence of lymphovascular or neu-
al invasion. It was discussed at MDM  and given the clear margins,
t was thought that beneﬁt from any further adjuvant treatment
ould be very minimal.
At  16 months post-metastectomy, he presented with recur-
ence at the previous excision site with CT scan raising suspicion
f involvement of the hepatic ﬂexure of the colon. Colonoscopy did
ot reveal mucosal involvement. The case was  again discussed at
he MDM  and given the localised nature of the recurrence, was
ffered further excision. At laparotomy, the hepatic ﬂexure was
ound to be involved with direct extension of the tumour form
he abdominal wall. He underwent an enbloc resection of the
kin/muscle/right hemicolectomy, with a Transverse rectus abdo-
inis muscle (TRAM) ﬂap transposed to ameliorate the abdominal
all defect. Histology conﬁrmed this to be identical to both the
riginal gastric adenocarcinoma and intramuscular nodule. He
ecovered uneventfully and was discharged on post operative day
. He remains disease free 3 months post-second metastectomy
Figs. 5–7)..  Discussion
In Western society, UGIT malignancy usually presents at a late
tage. Outcomes and survival rates are uniformly poor.1,2 The
Fig. 6. Abdominal wall metastasis.Fig. 7. TRAM ﬂap reconstruction post en bloc resection.
prognosis is further diminished in the presence of metastatic dis-
ease and the mainstay of treatment in Stage 4 disease has been
palliation. Whilst there have been case series reported on resection
of hepatic and, to a lesser degree, nodal metastases,9 there has
been very little published on the resection of isolated non-hepatic,
non-nodal metastases.
Cases  1 and 2 highlight the potential role of metastectomy with
a curative intent. The 30 month (patient 1) and 12 month (patient 2)
disease-free period post-resection show that, at least in the short
and intermediate term, it is a viable option in reasonably ﬁt and
healthy patients at least for isolated metastatic disease. Case 3 also
showcases this, although to a lesser degree. Surgical resection has
provided extended survival without compromising quality of life
in these patients. The morbidity of surgery was  very low. For the
second resection in case number three multidisciplinary approach
with plastic surgery input was invaluable. In short a careful con-
sideration for surgical resection should be given to ﬁt patients with
isolated, metachronous non-hepatic metastases of oesophagogas-
tric origin where an R0 resection is deemed feasible. Port et al.9 have
shown that resecting isolated metastases in the UGIT setting led to
an increase in median overall survival from 16.9% (chemotherapy)
to 34.6%. There have been a few case reports documenting potential
survival beneﬁts post-metastectomy, namely in the chest wall,10
small bowel,11 thyroid12 and skin.13
The long-term outcomes are not yet apparent in these cases and
time and further follow-up will reveal whether this approach will
be beneﬁcial to the Stage 4 patients in the long run, or whether it
merely represents another form of palliation.
4. Conclusion
Resection for isolated metastasis from oesophagogastric can-
cers may  be a viable option, especially if patients have minimal
co-morbidities.
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